High-throughput screening of biocatalytic activity: Applications in drug discovery

Current Opinion in Chemical Biology

Volumn 10, Issue 2, 2006, Pages 162-168

  Kumar, R Anand ^a   Clark, Douglas S ^a  

^a University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; LEAD; PHOSPHOTRANSFERASE INHIBITOR;

BIOCATALYST; DRUG METABOLISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; HIGH THROUGHPUT SCREENING; IMMOBILIZATION; LEACHING; MICROARRAY ANALYSIS; REVIEW; SCREENING; TOXICITY TESTING;

CATALYSIS; DRUG DESIGN; ENZYMES; PHARMACOKINETICS; TOXICITY TESTS;

EID: 33645218742     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2006.02.033     Document Type: Review

References (47)

1. R.F. Service Surviving the blockbuster syndrome Science 303 2004 1796 1799
2. A.S. Verkman Drug discovery in academia Am J Physiol Cell Physiol 286 2004 465 474
3. M.E.M. Noble, J.A. Endicott, and L.N. Johnson Protein kinase inhibitors: insights into drug design from structure Science 303 2004 1800 1805
4. E.M.J. Gillam Exploring the potential of xenobiotic-metabolizing enzymes as biocatalysts: evolving designer catalysts from polyfunctional cytochrome P450 enzymes Clin Exp Pharm Physiol 32 2005 147 152
5. C. Garrido, and G. Kroemer Life's smile, death's grin: vital functions of apoptosis-executing proteins Curr Opin Cell Biol 16 2004 639 646
6. H.M. Geysen, F. Schoenen, D. Wagner, and R. Wagner Combinatorial compound libraries for drug discovery: an ongoing challenge Nat Rev Drug Discov 2 2003 222 230
7. S. Fox, S. Farr-Jones, L. Sopchak, A. Boggs, and J. Comley High-throughput screening: searching for higher productivitiy J Biomol Screen 9 2004 354 358
8. S. Lombardi Industrializing microarrays Modern Drug Discovery 2004 46 48
9. C.R. Gardner, O. Almarsson, H. Chen, S. Morissette, M. Peterson, Z. Zhang, S. Wang, A. Lemmo, J. Gonzalez-Zugasti, and J. Monagle Application of high-throughput technologies to drug substance and drug product development Comp Chem Eng 28 2004 943 953
10. O. von Ahsen, and U. Bomer High-throughput screening for kinase inhibitors ChemBioChem 6 2005 481 490
11. A. Shah How to choose an in vitro kinase assay Drug Discov Dev 7 2004 59 62
12. J.H. Ansede, and D.R. Thakker High-throughput screening for stability and inhibitory activity of compounds toward cytochrome P450-mediated metabolism J Pharm Sci 93 2004 239 255
13. M. Coles, M. Heller, and H. Kessler NMR-based screening technologies Drug Discov Technol 8 2003 803 810
14. D.B. Kassel Applications of high-throughput ADME in drug discovery Curr Opin Chem Biol 8 2004 339 345
15. 50 measurements performed at unprecedentedly low enzyme concentration Drug Dev Res 64 2005 105 113
16. C.B. Park, and D.S. Clark Sol-gel encapsulated enzyme arrays for high-throughput screening of biocatalytic activity Biotechnol Bioeng 78 2002 229 235 Enzymes encapsulated in sol-gels, referred to as solzymes, are used in a low-cost and reusable multi-well platform for high-throughput biocatalytic assays.
17. N. Rupcich, J.R. Green, and J.D. Brennan Nanovolume kinase inhibition assay using a sol-gel-derived multicomponent microarray Anal Chem 77 2005 8013 8019
18. D.R. Groebe, M.L. Maus, T. Pederson, J. Clampit, S. Djuric, J. Trevillyan, C.W. Lin, D.J. Burns, and U. Warrior Putting thought to paper: a μARCS protease screen J Biomol Screen 8 2003 668 675 A high-throughput platform called μARCS was used to screen for protease inhibitors. Enzyme-encapsulated agarose gel was contacted with a sheet of arrayed compounds and a substrate gel/sheet. The gel matrix acts as a reaction vessel and the inhibitors are identified using fluorescent probes.
19. S.N. Anderson, B.L. Cool, L. Kifle, W. Chiou, D.A. Egan, L.W. Barrett, P.L. Richardson, E.U. Frevert, U. Warrior, and J.L. Kofron Microarrayed compound screening (μARCS) to identify activators and inhibitors of AMP-activated protein kinase J Biomol Screen 9 2004 112 121
20. P. Babiak, and J.-L. Reymond A high-throughput, low-volume enzyme assay on solid support Anal Chem 77 2005 373 377
21. G. MacBeath, and S.L. Schreiber Printing proteins as microarrays for high-throughput function determination Science 289 2000 1760 1763
22. J.S. Merkel, G.A. Michaud, M. Salcius, B. Schweitzer, and P.F. Predki Functional protein microarrays: just how functional are they? Curr Opin Biotechnol 16 2005 447 452
23. G.Y.J. Chen, M. Uttamchandani, Q. Zhu, G. Wang, and S.Q. Yao Developing a strategy for activity-based detection of enzymes in a protein microarray ChemBioChem 4 2003 336 339 The first demonstration of direct enzyme immobilization on glass slides for high-throughput activity assays and screening of enzyme inhibitors. Mechanism-based fluorescent probes were used to identify inhibitors of cysteine proteases, serine hydrolases, and phosphatases.
24. J. Eppinger, D.P. Funeriu, M. Miyake, L. Denizot, and J. Miyake Enzyme microarrays:On-chip determination of inhibition constants based on affinity-label detection of enzymatic activity Angew Chem Int Ed Engl 43 2004 3806 3810 An immobilized protein microarray was used in conjunction with activity-dependent fluorescent labels to characterize the kinetics of cysteine proteases and the mechanism of protease inhibitors.
25. M. Schutkowski, U. Reineke, and U. Reimer Peptide arrays for kinase profiling ChemBioChem 6 2005 513 521
26. S. Panse, L. Dong, A. Burian, R. Carus, M. Schutkowski, U. Reimer, and J. Schneider-Mergener Profiling of generic anti-phosphopeptide antibodies and kinases with peptide microarrays using radioactive and fluorescence-based assays Mol Divers 8 2004 291 299
27. C.M. Salisbury, D.J. Maly, and J.A. Ellman Peptide microarrays for the determination of protease substrate specificity J Am Chem Soc 124 2002 14868 14870
28. M. Uttamchandani, X. Huang, G.Y.J. Chen, and S.Q. Yao Nanodroplet profiling of enzymatic activities in a microarray Bioorganic and Med Chem Lett 15 2005 2135 2139
29. D.-S. Shin, D.-H. Kim, W.-J. Chung, and Y.-S. Lee Combinatorial solid phase peptide synthesis and bioassays J Biochem Mol Biol 38 2005 517 525
30. P. Angenendt, H. Lehrach, J. Kreutzberger, and J. Glokler Subnanoliter enzymatic assays on microarrays Proteomics 5 2005 420 425
31. D.N. Gosalia, and S.L. Diamond Printing chemical libraries on microarrays for fluid phase nanoliter reactions Proc Natl Acad Sci USA 100 2003 8721 8726 A novel approach to biocatalytic assays on a microarray without the need for physical or covalent immobilization of enzymes. Nanoliter volume reactions were used to screen inhibitors against caspases, thrombin and chymotrypsin.
32. D.N. Gosalia, C.M. Salisbury, D.J. Maly, J.A. Ellman, and S.L. Diamond Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays Proteomics 5 2005 1292 1298
33. 50 profiling Assay Drug Dev Technol 3 2005 177 187
34. M. MacCoss, and T.A. Baillie Organic chemistry in drug discovery Science 303 2004 1810 1813
35. L.C. Wienkers, and T.G. Heath Predicting in vivo drug interactions from in vitro drug discovery data Nat Rev Drug Discov 4 2005 825 833
36. O.V. Trubetskoy, J.R. Gibson, and B.D. Marks Highly miniaturized formats for in vitro drug metabolism assays using Vivid fluorescent substrates and recombinant human cytochrome P450 enzymes J Biomol Screen 10 2005 56 66
37. M. Koppitz, A. Brailsford, and M. Wenz Maximizing automation in LC/MS high-throughput analysis and purification J Comb Chem 7 2005 714 720
38. S.X. Peng, A.G. Barbone, and D.M. Ritchie High-throughput cytochrome P450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns Rapid Commun Mass Spectrom 17 2003 509 518 A significant increase in the throughput of LC/MS by sample pooling techniques and ultrafast chromatography.
39. R. Xu, C. Nemes, K.M. Jenkins, R.A. Rourick, and D.B. Kassel Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries J Am Soc Mass Spectrom 13 2002 155 165
40. K. Sakai-Kato, M. Kato, H. Homma, T. Toyo'oka, and N. Utsunomiya-Tate Creation of a P450 array toward high-throughput analysis Anal Chem 77 2005 7080 7083
41. M.-Y. Lee, C.B. Park, J.S. Dordick, and D.S. Clark Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses Proc Natl Acad Sci USA 102 2005 983 987 A powerful approach for rapid screening of drugs and drug candidates for cytotoxicity, using nanoliter volume sol-gel encapsulated CYPs on a glass slide for the generation of metabolites. The cytotoxicity profiles obtained from the microarray are comparable to those obtained by conventional well-plate assays.
42. K. Kupcho, K. Hsiao, B. Bulleit, and S.A. Goueli A homogeneous, nonradioactive high-throughput fluorogenic protein phosphatase assay J Biomol Screen 9 2004 223 231
43. S. Kumaraswamy, T. Bergstedt, X. Shi, F. Rininsland, S. Kushon, W. Xia, K. Ley, K. Achyuthan, D. McBranch, and D. Whitten Fluorescent-conjugated polymer superquenching facilitates highly sensitive detection of proteases Proc Natl Acad Sci USA 101 2004 7511 7515
44. E.E.M.G. Loomans, A.M. van Doornmalen, J.W.Y. Wat, and G.J.R. Zaman High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases Assay Drug Dev Technol 1 2003 445 453
45. J.R. Beasley, P.M. McCoy, T.L. Walker, and D.A. Dunn Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassays Assay Drug Dev Techol 2 2004 141 151
46. W. Zheng, P.E. Brandish, D.G. Kolodin, E.M. Scolnick, and B. Strulovict High-throughput cell-based screening using scintillation proximity assay for the discovery of inositol phosphatase inhibitors J Biomol Screen 9 2004 132 140
47. M. Koresawa, and T. Okabe High-throughput screening with quantitation of ATP consumption: a universal non-radioisotope, homogeneous assay for protein kinase Assay Drug Dev Techol 2 2004 153 160